THE EFFECTS OF CIGARETTE SMOKING ON GLYCOSYLATED HEMOGLOBIN (HbA1C) IN NON-DIABETIC INDIVIDUALS
Abstract
Abstract : Background Cigarette smoking
is associated with an increased risk of
Type 2 diabetes mellitus. Cigarette smoking
is known to cause a transient elevation
in blood glucose concentration. Glycosylated
hemoglobin (HbA1c) is a marker of
long-term glucose homeostasis reflecting
an average blood glucose concentration in
past 2-3 months. The effect of cigarette
smoking on average blood glucose levels
as measured by glycosylated hemoglobin
have yet received little attention. Aim and
Objective This study was done to assess
the effect of smoking on blood glucose
concentration by comparing glycosylated
hemoglobin (HbA1c) between non-diabetic
c igarette smokers and nonsmokers.
Materials and Methods This is a
cross sectional case control study involving
60 participants. Of them case group
consists of 30 non-obese, non-diabetic
males of age group between 20-40 years
who smoke 10 filter cigarettes per day or
more for not less than 5 years. 30 healthy
age matched non-obese males who do not
smoke cigarette were recruited for control
group.
After an overnight fast of 12 hours the serum
glucose concentration and the glycosylated
hemoglobin levels were estimated
in all subjects and the values were compared
between the cases and control using
students t test.Results There is no significant
increase in the fasting serum glucose
levels between the cases100.212.37
and the controls 103.19.64. There is a significant
increase in the glycosylated hemoglobin
level in smokers 5.480.83 when
compared with the non-smokers 4.560.34
with p-value 0.001.Conclusion The results
from the present study suggest that the
level of glycosylated hemoglobin is increased
in the non-diabetic smokers when
compared to the non-smokers.
Keyword :Key wordsCigarette smokers,
non-smokers, non-diabetic, glycosylated
hemoglobin.
Full Text:
PDFReferences
Janson L, Berntorp K, Hanson M, Lindell
SE, Trell E. Glucose tolerance and
smoking: a population study of oral and
intravenous glucose tolerance in middleaged
man. Diabetologia, 1983;25: 86-88.
Eliasson B, Attavall S, Taskinen
MR, Smith U. The insulin resistance
syndrome in smokers isrelated to
smoking habits. Arterioscler Thromb,
; 14: 1946-1950.
Feskens EJ, Kromhout D. Cardiovascular
risk factors and 25-year incidence
of diabetes mellitusin middleaged
men. The Zutphen study. Am J
Epidemiol, 1989; 130: 110-08.
Rimm EB, Manson JE, Stampler
MJ et al. Cigarette smoking and risk
of diabetes in women. AmJ public
health, 1993: 83: 211-14.
Engelgau MM, Thompson TJ,
Herman WH et al. Comparison of
fasting 2-hour glucose and HbA1c levels
for diagnosing diabetes. Diabetes
care, 1997: 20: 785-91.
Park S, Barret CE, Wingard DL,
Shan J, Ederlstein S. GHb is a better
predictor ofcardiovascular disease
than fasting or postchallenge plasma
glucose in women without diabetes.
The Rancho Bernardo study. Diabetes
care, 1996; 19: 450-56.
Urberg M, Shamma R, Rajdev K.
The effects of cigarette smoking on
glycosylated hemoglobin in nondiabetic
individual. J Fam pract May,
; 28(5): 529-31.
Lincoln A Sargeant, Kay-Tee
Khaw, Sheila Bingham, Nicholas E
Day, Robert N Luben, Suzy Oakes,
Ailsa Welch and Nicholas J Wareham.
Cigarette smoking and glycaemia:
the EPIC-Norfolk study. International
Journal of Epidemiology, 2001;
:547-554
Cryer PE, Haymond MW, Santiago JV,
Shah SD; Norepinephrine and epinephrine
release and adrenergic mediation of smoking-
associated hemodynamic and metabolic
events. J Engl J Med, 1976: 295: 573
-577.
Bearn AG, Billing B, Sherlock S: The
effect of adrenaline and nor-adrenaline on
hepatic blood flow and splanchnic carbohydrate
metabolism in man. J Physiol
(Lond), 1951; 115: 430-441.
Vani Gupta, Sunitha Tiwari, Agarwal C
G, Pallavi Shukla, Harish Chandra and
Pooja Sharma. Effect of short term cigarette
smoking on insulin resistance and
lipid profile in asymptomatic adults. Indian
J Physio Pharmacol, 2006; 50(3): 285-290.
Ronnemaa T, Ronnemaa EM. Puukka
P, Pyorala K, Laakso M. Smoking is independently
associated with high plasma insulin
levels in nondiabetic men. Diabetes
care, 1996; 19: 1229-32.
Givovanni Targher, Maria Alberiche,
Marina B. Zenere, Riccardo C. Bonadonna,
Michele Muggero, Enzo Bonora.
Cigarette smoking and Insulin resistance
in patients with Noninsulin-dependant diabetes
mellitus. Journal of Clinical Endocrinology
and Metabolism, 1997; 89(11):
-3624.
Morrow JD, Frei B, Longmire Aw et
al., Increase in circulating products of lipid
peroxidation (F2-isoprostanes) in smokers.
Smoking as a cause of oxidative damage,
N Engl J Med 1995; 332: 1198- 203.
Paolisso G, D’Amore A, Volpe C. Evidence
for a relationship between oxidative
stress and insulinaction in
non-insulin-dependent (type II) diabetic
patients. Metabolism, 1994; 43:
-29.
Philip E. Cryer, Morey W Haymond,
Julio V. Santiago, Suresh D.
Shah. Norepinephrine andepinephrine
release and adrenergic mediation
of smoking-associated hemodynamic
and metabolicevents. N Engl J
Med, 1976; 295: 573-577.
Venkatesan A, Hemalatha A,
Zachariah Bobby, Selvaraj N, Sathiyapriya
V. Nonenzymaticglycation of
plasma proteins in smokers. Indian J
Physio Pharmacol, 2006; 50(4): 403-
Tietz Fundatmentl of clinical
chemistry. Carl A. Burtis, Edward R.
Ashwodd. 5t h edition, 2001,
W.B.Saunders Company.
Harrison’s Principles of Internal
Medicine. Antony S.Fauci, Eugene
Braunwald, Dennis L. Kasper,
Stephen L. Hauser, Dan L. Lango,
Larry Jameson, Joseph Localzo. 17th
edition, 2008, Mc Graw Hill Companies.
Harper’s Illustrated Biochemistry.
Robert K. Murray, David A. Bender,
Kathleen M. Botham, Peter J. Kennelly.
th edition, 2009, Lange Publications.
Davidson’s Principles and Practice
of Medicine. Nicki R. Colledge,
Brian R. Walker, Stuart H.
Ralston. 21st edition, 2010, Elsevier Limited.
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
An Initiative of The Tamil Nadu Dr M.G.R. Medical University